(Q50975036)

English

Histone deacetylase (HDAC) inhibitors as single agents induce multiple myeloma cell death principally through the inhibition of class I HDAC.

scientific article published on 21 May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23692150

Histone deacetylase (HDAC) inhibitors as single agents induce multiple myeloma cell death principally through the inhibition of class I HDAC. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23692150

Sridurga Mithraprabhu

1

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23692150

author name string

Tiffany Khong

2

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23692150

Simon S Jones

3

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23692150

Andrew Spencer

4

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23692150

language of work or name

0 references

publication date

21 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23692150

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23692150

162

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23692150

4

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23692150

559-562

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23692150

The role of HDAC6 in cancer

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12388

21 January 2018

Development of the pan-DAC inhibitor panobinostat (LBH589): successes and challenges

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12388

21 January 2018

A high rate of durable responses with romidepsin, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12388

21 January 2018

Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12388

21 January 2018

Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12388

21 January 2018

Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12388

21 January 2018

Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12388

21 January 2018

Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12388

21 January 2018

Identifiers

10.1111/BJH.12388

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23692150

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/23692150

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50975036&oldid=1108077519"